126 related articles for article (PubMed ID: 23257430)
21. [Interim results of a multicenter cohort study for Chinese Children Leukemia Group-acute lymphoblastic leukemia 2018 regimen].
Chinese Children Leukemia Group
Zhonghua Er Ke Za Zhi; 2023 Oct; 61(10):874-880. PubMed ID: 37803853
[No Abstract] [Full Text] [Related]
22. Role of peripheral blood minimum residual disease at day 8 of induction therapy in high-risk pediatric patients with acute lymphocytic leukemia.
Salina TD; Ferreira YA; Alves EB; Ferreira CM; De Paula EV; Mira MT; Passos Lda M
Sci Rep; 2016 Aug; 6():31179. PubMed ID: 27526794
[TBL] [Abstract][Full Text] [Related]
23. Flow Cytometry Based MRD and Its Impact on Survival Outcome in Children and Young Adults with ALL: A Prospective Study from a Tertiary Cancer Centre in Southern India.
Panda SS; Radhakrishnan V; Ganesan P; Rajendranath R; Ganesan TS; Rajalekshmy KR; Bhola RK; Das H; Sagar TG
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):300-308. PubMed ID: 32425381
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics and prognostic analysis of children and adolescents over 10 years of age with acute lymphoblastic leukemia].
Wu J; Lu AD; Zhang LP
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Jun; 19(6):614-619. PubMed ID: 28606225
[TBL] [Abstract][Full Text] [Related]
25. Treatment of adult patients with acute lymphoblastic leukemia in the Czech Republic in the period 2007-2020.
Šálek C; Hrabovský Š; Folber F; Horáček JM; Kořístek Z; Szotkowski T; Pecherková P; Froňková E; Doubek M; Leukemická Skupina-Pro Život Cell Č
Klin Onkol; 2023; 36(4):382-395. PubMed ID: 37877531
[TBL] [Abstract][Full Text] [Related]
26. Genes contributing to minimal residual disease in childhood acute lymphoblastic leukemia: prognostic significance of CASP8AP2.
Flotho C; Coustan-Smith E; Pei D; Iwamoto S; Song G; Cheng C; Pui CH; Downing JR; Campana D
Blood; 2006 Aug; 108(3):1050-7. PubMed ID: 16627760
[TBL] [Abstract][Full Text] [Related]
27. FCM marker importance for MRD assessment in T-cell acute lymphoblastic leukemia: An AIEOP-BFM-ALL-FLOW study group report.
Kowarsch F; Maurer-Granofszky M; Weijler L; Wödlinger M; Reiter M; Schumich A; Feuerstein T; Sala S; Nováková M; Faggin G; Gaipa G; Hrusak O; Buldini B; Dworzak MN
Cytometry A; 2024 Jan; 105(1):24-35. PubMed ID: 37776305
[TBL] [Abstract][Full Text] [Related]
28. Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in China.
Leung KT; Cai J; Liu Y; Chan KYY; Shao J; Yang H; Hu Q; Xue Y; Wu X; Guo X; Zhai X; Wang N; Li X; Tian X; Li Z; Xue N; Guo Y; Wang L; Zou Y; Xiao P; He Y; Jin R; Tang J; Yang JJ; Shen S; Pui CH; Li CK
Leukemia; 2024 Feb; 38(2):250-257. PubMed ID: 38001171
[TBL] [Abstract][Full Text] [Related]
29. [Clinical characteristics and prognosis of 28 cases of infant acute lymphoblastic leukemia].
Shi Y; Lu Y; Zhang RD; Zhang YY; Lin W; Yu JJ; Wu Y; Fan J; Qi PJ; Huang PL; Cai LX; Huang Q; Zhang P; Sun YM; Liu Y; Zheng HY
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):49-54. PubMed ID: 38154977
[No Abstract] [Full Text] [Related]
30. A set of genes that regulate cell proliferation predicts treatment outcome in childhood acute lymphoblastic leukemia.
Flotho C; Coustan-Smith E; Pei D; Cheng C; Song G; Pui CH; Downing JR; Campana D
Blood; 2007 Aug; 110(4):1271-7. PubMed ID: 17456722
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic significance of cerebrospinal fluid flow cytometry in Chinese children with B lineage acute lymphoblastic leukemia.
Tang X; Mai H; Wang L; Chen S; Chen F; Li T; Liu Y; Zhou G; Liu S; Wang Y; Liu S; Fu X; Wen F
BMC Pediatr; 2024 Mar; 24(1):204. PubMed ID: 38519960
[TBL] [Abstract][Full Text] [Related]
32. Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Faulk KE; Kairalla JA; Dreyer ZE; Carroll AJ; Heerema NA; Devidas M; Carroll WL; Raetz EA; Loh ML; Hunger SP; Borowitz M; Wang C; Guest E; Brown PA
Pediatr Blood Cancer; 2023 May; ():e30467. PubMed ID: 37259259
[TBL] [Abstract][Full Text] [Related]
33. The importance of minimal residual disease for detection of late relapse in Bprecursor acute lymphoblastic leukemia.
Virijevic M; Kraguljac-Kurtovic N; Pantic N; Knezevic V; Mitrovic M
Hippokratia; 2022; 26(1):38-40. PubMed ID: 37124277
[TBL] [Abstract][Full Text] [Related]
34. Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Buchmann S; Schrappe M; Baruchel A; Biondi A; Borowitz M; Campbell M; Cario G; Cazzaniga G; Escherich G; Harrison CJ; Heyman M; Hunger SP; Kiss C; Liu HC; Locatelli F; Loh ML; Manabe A; Mann G; Pieters R; Pui CH; Rives S; Schmiegelow K; Silverman LB; Stary J; Vora A; Brown P
Blood; 2022 Mar; 139(12):1785-1793. PubMed ID: 34192312
[TBL] [Abstract][Full Text] [Related]
35. Cytogenetic Risk Stratification of B-Acute Lymphoblastic Leukemia and Its Correlation with Other Prognostic Factors.
Chadha R; Udayakumar DS; Sangwan S; Gore A; Jha B; Goel S; Mathur N; Rastogi N; Dixit R; Sood N; Yadav SP; Saxena R
Indian J Hematol Blood Transfus; 2023 Jan; 39(1):141-145. PubMed ID: 36699427
[TBL] [Abstract][Full Text] [Related]
36. MRD and EFS in pediatric T-lymphoblastic lymphoma.
Blood; 2024 May; 143(20):2111. PubMed ID: 38753360
[No Abstract] [Full Text] [Related]
37. STAT5 phosphorylation plus minimal residual disease defines a novel risk classification in adult B-cell acute lymphoblastic leukaemia.
Xu X; Huang Z; Ding C; Deng S; Ou J; Cai Z; Zhou Y; Liang H; Chen J; Wang Z; Liu X; Xuan L; Liu Q; Zheng Z; Li Z; Zhou H
Br J Haematol; 2024 Apr; ():. PubMed ID: 38639167
[TBL] [Abstract][Full Text] [Related]
38. A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL.
Popov A; Henze G; Roumiantseva J; Bydanov O; Belevtsev M; Verzhbitskaya T; Movchan L; Tsaur G; Lagoyko S; Zharikova L; Myakova N; Litvinov D; Khlebnikova O; Streneva O; Stolyarova E; Ponomareva N; Novichkova G; Fechina L; Aleinikova O; Karachunskiy A
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067249
[TBL] [Abstract][Full Text] [Related]
39. Advances in Monitoring and Prognostication for Lymphoma by Flow Cytometry.
Singh AP; Courville EL
Clin Lab Med; 2023 Sep; 43(3):351-361. PubMed ID: 37481316
[TBL] [Abstract][Full Text] [Related]
40.
Torres-Llanos Y; Zabaleta J; Cruz-Rodriguez N; Quijano S; Guzmán PC; de Los Reyes I; Poveda-Garavito N; Infante A; Lopez-Kleine L; Combita AL
Front Mol Biosci; 2024; 11():1385140. PubMed ID: 38745909
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
